ADAKVEO Co-Pay Program

Manufacturer copay assistance · Adakveo (J0791) · Pfizer (acquired from Novartis)

Eligible patients pay $0… · Maximum benefit Up to $15,000/year. $25 per prescription patient cost. · Covers Adakveo drug copay only — does NOT cover infusion administration

Program terms

Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.

Assistance type

Copay Assist

Patient pays

Eligible patients pay $0 (or low fixed cost — see notes)

Maximum benefit

Up to $15,000/year. $25 per prescription patient cost.

What it covers

Covers Adakveo drug copay only — does NOT cover infusion administration

Insurance

commercial no medicare no medicaid no tricare no va no government

Renewal

annual

Medicare or Medicaid patient?

This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.

CLOSED

Sickle Cell Disease

HealthWell Foundation · Up to $10,000

CLOSED

Sickle cell disease (SCD)

PAN Foundation · Up to $5,600/year

Common questions

Does Adakveo have a copay card?

Yes — ADAKVEO Co-Pay Program from Pfizer (acquired from Novartis). Eligible patients pay $0 (or low fixed cost — see notes). Commercial insurance is required; Medicare and Medicaid patients are not eligible.

How much does Adakveo cost with the copay card?

Eligible patients pay $0 (or low fixed cost — see notes) Maximum benefit: Up to $15,000/year. $25 per prescription patient cost.. Covers Adakveo drug copay only — does NOT cover infusion administration

Who is eligible for ADAKVEO Co-Pay Program?

Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.